Back to today’s briefing

Story perspectives

UK's £11 Billion Pharma Investment Loss Threatens Public Health

6/5/2025

29 5

Summary

Story summary

The UK faces a staggering £11 billion loss in pharmaceutical research and development investment by 2033, driven by excessive sales clawbacks, warns WPI Economics. Industry leaders are calling on the government to revamp the VPAG rebate system, emphasizing that inaction could jeopardize patient access, public health, and the nation's economic standing on the global stage.

1 of 1

Story summary

The UK faces a staggering £11 billion loss in pharmaceutical research and development investment by 2033, driven by excessive sales clawbacks, warns WPI Economics. Industry leaders are calling on the government to revamp the VPAG rebate system, emphasizing that inaction could jeopardize patient access, public health, and the nation's economic standing on the global stage.